ANDA 74051, held by Apothecon. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74051 (Diltiazem Hydrochloride), held by Apothecon, was first approved by FDA on Mar 31, 1993, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 1993 | Original application | Approved | None posted |
| Diltiazem Hydrochloride30MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride60MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride90MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride120MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Sep 24, 1997 | Supplement 9Labeling | Approved | None posted |
| Jun 27, 1997 | Supplement 8Labeling | Approved | None posted |
| Aug 26, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Dec 8, 1995 | Supplement 6Manufacturing | Approved | None posted |
| Dec 8, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Dec 8, 1995 | Supplement 4Manufacturing | Approved | None posted |
| Jan 19, 1995 | Supplement 3Labeling | Approved | None posted |
| Sep 22, 1994 | Supplement 2Manufacturing | Approved | None posted |
| Sep 9, 1993 | Supplement 1Manufacturing | Approved | None posted |
| Mar 31, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters